Operating Lease, Right-of-Use Asset of GoodRx Holdings, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GoodRx Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • GoodRx Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $29,694,000, a 3% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GoodRx Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $29,694,000 +$852,000 +3% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $30,692,000 +$799,000 +2.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $22,898,000 -$8,030,000 -26% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $27,794,000 -$2,135,000 -7.1% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $28,842,000 -$2,659,000 -8.4% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $29,893,000 -$3,645,000 -11% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $30,928,000 -$3,988,000 -11% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $29,929,000 +$21,029,000 +236% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $31,501,000 +$3,530,000 +13% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $33,538,000 +$5,031,000 +18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $34,916,000 +$7,938,000 +29% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $8,900,000 -$11,300,000 -56% 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $27,971,000 +$2,002,000 +7.7% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $28,507,000 +$1,605,000 +6% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $26,978,000 -$905,000 -3.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $20,200,000 -$7,512,000 -27% 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $25,969,000 -$3,349,000 -11% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $26,902,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $27,883,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $27,712,000 -$4,603,000 -14% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $29,318,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 $32,315,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.